SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).
SUDOSCAN has demonstrated its clinical utility in Nephrology.
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.
Le brevet N ° 8934954 a été obtenu le 13 Janvier 2015 :
« Évaluation de la fonction sudomotor pour périphérique d’évaluation de neuropathie diabétique » .
September 14, 2024